Request to convene Extraordinary General Meeting of Diagnostyka

Date: 26 March 2025

Subject: Request to convene Extraordinary General Meeting of Diagnostyka

Legal basis: Article 17(1) of MAR – Inside information

Text of the report:

The Management Board of Diagnostyka S.A. (the “Company”) announces that on 26 March 2025 it received a request to convene an Extraordinary General Meeting from the Company’s shareholders Grzegorz Głownia, Jacek Prusek and Jakub Swadźba, representing jointly one-twentieth or more of the Company’s share capital. The request includes a motion to vote on resolutions on the appointment of three members to the Supervisory Board (Patrycja Swadźba, Paweł Leżański and Piotr Solorz), as well as to pass a resolution regarding remuneration of the Supervisory Board members.

The request is attached as an appendix hereto.

The Management Board also announces that the General Meeting will be convened in accordance with applicable laws, and the notice and agenda of the General Meeting will be published in a separate report and posted on the Company’s website.

Specific legal basis: Article 17(1) of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and repealing Directive 2003/6/EC of the European Parliament and of the Council and Commission Directives 2003/124/EC, 2003/125/EC and 2004/72/EC (OJ L 173) (“MAR”).

For the Company:

Jakub Swadźba – CEO, President of the Management Board

Paweł Chytła – Vice President of the Management Board